Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
FOXO Technologies ( (FOXO) ) has issued an announcement.
On June 17, 2025, FOXO Technologies Inc. announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, has started offering wound care services for both inpatient and outpatient needs. This expansion is in response to increasing demand, particularly from diabetic patients, and is expected to boost net revenues while potentially expanding market reach with additional services.
Spark’s Take on FOXO Stock
According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.
FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.
To see Spark’s full report on FOXO stock, click here.
More about FOXO Technologies
FOXO Technologies Inc. operates in the biotechnology industry and owns three subsidiaries: Rennova Community Health, Inc., which operates a critical access hospital in East Tennessee; Myrtle Recovery Centers, Inc., a behavioral health facility; and FOXO Labs, Inc., a biotechnology company focused on improving human health and lifespan through advanced technology.
Average Trading Volume: 5,590,834
Technical Sentiment Signal: Sell
Current Market Cap: $2.21M
For an in-depth examination of FOXO stock, go to TipRanks’ Overview page.